cancer clinical trials in lecanto, FL

Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone

Cancer & Blood Disease Center
Lecanto, Florida 34461

Multiple Myeloma

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Cancer & Blood Disease Center
Lecanto, Florida 34461

Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

Cancer and Blood Disease Center
Lecanto, Florida 34461

Relapsed Multiple Myeloma

Connect® MM- The Multiple Myeloma Disease Registry

Cancer & Blood Disease Center
Lecanto, Florida 34461

Multiple Myeloma

Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)

Cancer and Blood Disease Center
Lecanto, Florida 34461

Ovarian Cancer

A Phase 3 Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma

Cancer and Blood Disease Center
Lecanto, Florida 34461

Relapsed Multiple Myeloma, Refractory Multiple Myeloma

Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes

Cancer & Blood Disease Center
Lecanto, Florida 34461

Myelodysplastic Syndromes

Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality

Cancer & Blood Disease Center
Lecanto, Florida 34461

Myelodysplastic Syndromes

Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma

Cancer and Blood Disease Center
Lecanto, Florida 34461

Lymphoma

TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer

Cancer and Blood Disease Center
Lecanto, Florida 34461

Ovarian Neoplasms

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Cancer and Blood Disease Center
Lecanto, Florida 34461

Carcinoma, Non-Small Cell Lung

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

Cancer & Blood Disease Center
Lecanto, Florida 34461

NSCLC

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Cancer and Blood Disease Center
Lecanto, Florida 34461

Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary

Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

Cancer and Blood Disorders Center
Lecanto, Florida 34461

Multiple Myeloma

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

Cancer & Blood Disease Center
Lecanto, Florida 34461

Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic

Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

Cancer & Blood Disease Center
Lecanto, Florida 34461

Myelodysplastic Syndrome

Join the directory

Join the Community

Join the Directory